How Singular? How singular is the Singularity? Will it happen in an instant? Lets consider again the derivation of the word. In mathematics a singularity is a value that is beyond any limit - in essence, infinity. The Singularity as we have discussed it in this book, does not achieve infinite levels of computation, memory, as any other other measurable attribute. But it certainly achieves vast levels of all these qualities, including intelligence. With the reverse engineering of the human brain we will be able to apply the parallel, self-organizing, chaotic, algorithms of human intelligence to enormously powerful computational substrates. This intelligence will then be in a position to improve its own design, both hardware and software, in a rapidly accelerating iterative process.

"This successor volume to The Singularity Is Near explores how technology will refashion the human race in the decades to come. In this entirely new book, Ray Kurzweil brings a fresh perspective to advances in the singularity-assessing the progress of many of his predictions and examining the novel advancements that, in the near future, will bring a revolution in knowledge and an expansion of human potential. Among the topics he discusses are rebuilding the world atom by atom with devices like nanobots; radical life extension beyond the current age limit of 120; reinventing intelligence by expanding biological capacity with nonbiological intelligence in the cloud; how life is improving with declines in poverty and violence; and the growth of technologies that can be applied to everything from clothes to building materials to growing human organs. He also considers the potential perils of biotechnology, nanotechnology, and artificial intelligence, including such topics as how AI will impact unemployment and the safety of autonomous cars, and "After Life" technology, which will reanimate people who have passed away through a combination of data and DNA"--

The exclusive, first-hand, behind-the-scenes story of how Pfizer raced to create the first Covid-19 vaccine, told by Pfizer's CEO Dr. Albert Bourla A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made "the impossible possible"--creating, testing, and manufacturing a safe and effective Covid-19 vaccine that previously would have taken years to develop. Dr. Bourla chronicles how the brilliant, dedicated minds at Pfizer, under the enormous strains of the global pandemic, overcame a series of crises that were compounded by social and political unrest, and reveals the doubts, decisions, obstacles, and failures they encountered. As Dr. Bourla makes clear, Pfizer's success wasn't due to luck; it was because of preparation driven by four simple values--Courage, Excellence, Equity, and Joy. Moonshot is a story of leadership under the most unprecedented circumstances--how Dr. Bourla, a Greek immigrant, a child of Holocaust survivors, and a veterinarian, became the head of one of the world's largest corporations and initiated a dramatic transformation of the organization just before a global health crisis would serve to test the organization, its scientists and its leader, like never before. Moonshot describes best practices that can be used to address the multiple, unprecedented challenges our world faces, reveals Pfizer's implementation of scientific breakthroughs at a record-breaking pace, and offers leadership lessons that can help anyone successfully manage their own seemingly unsolvable problems. As Dr. Bourla explains, "I am sharing the story of our moonshot--the challenges we faced, the lessons we learned, and the core values that allowed us to make it happen--in hopes that it might inspire and inform your own moonshot, whatever that may be."

Our fates lie in our genes and not in the stars, said James Watson, co-discoverer of the structure of DNA. But Watson could not have predicted the scale of the industry now dedicated to this new frontier. Since the launch of the multibillion-dollar Human Genome Project, the biosciences have promised miraculous cures and radical new ways of understanding who we are. But where is the new world we were promised? Now updated with a new afterword, Genes, Cells and Brains asks why the promised cornucopia of health benefits has failed to emerge and reveals the questionable enterprise that has grown out of bioethics. The authors, feminist sociologist Hilary Rose and neuroscientist Steven Rose, examine the establishment of biobanks, the rivalries between public and private gene sequencers, and the rise of stem cell research. The human body is becoming a commodity, and the unfulfilled promises of the science behind this revolution suggest profound failings in genomics itself.

"A collection of diverse viewpoints from over 45 thought leaders in the biotechnology industry and their efforts going forward during the COVID-19 pandemic. Biotechnology in the Time of COVID-19 is the opening chapter of a story of how the biotechnology industry rose to battle the COVID-19 virus-told by the leaders of that industry in their own words. The industry has built over more than forty years, an ecosystem of scientists, entrepreneurs, doctors, investors, venture capitalists, analysts, media, and bankers, all committed to advancing global health. In two months, leaders and companies from this ecosystem pivoted from the work they were carrying on pre-COVID-19 to face the virus. Forty-six seven contributors offer historical, personal, and investor perspectives, views from inside the biotech companies, broad lessons, leadership, and a look to the future. COVID-19 was a crisis anticipated by many, but one for which we were inadequately prepared. That has led to an unnecessary catastrophe. Now is the time to shine a light on those who bring hope that we will push back the virus with science and medicine. This book is a collection of the voices from the front of that fight. All share the commitment to fight and the conviction that science and medicine will prevail. The editor royalties and a portion of publisher revenues will be donated to two nonprofits focused on rare disease research: Global Genes (globalgenes.org) and The Institute for Life Changing Medicines (lifechangingmedicines.org)"--

This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work is in the "public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.

One of the most impassioned debates to have recently gripped Australian politicians and the public at large has been about the use of embryonic stem cells in medical research. This book examines all the issues.

Biotechnology (BT) offers exciting and promising prospects for healing the sick and relieving the suffering. But because of their impressive powers to alter the workings of body and mind, the "dual uses" of the same technologies make them attractive also to people who are not sick but who would use them to look younger, perform better, feel happier, or become more "perfect." These applications of BT present us with difficult challenges. This report considers such possible "beyond therapy" uses and explores both their scientific basis and the ethical and social issues they will raise. In enjoying the benefits of BT, we will need to hold fast to an account of the human being, seen not in material or mechanistic or med. terms, but in psychic and moral and spiritual ones.

Meet Phil Snyder: new father, nursing assistant at a cutting-edge biotech facility on Staten Island, and all-around decent guy. Trouble is, his life is falling apart. His wife has betrayed him, his job involves experimental surgeries with strange side effects, and his father is hiding early-onset dementia. Phil also has a special talent he doesn't want to publicize--he's a mind reader and moonlights as Brainstorm, a costumed superhero. But when Phil wakes up from a blackout drunkand is confronted with photos that seem to show him assaulting an unknown woman, even superpowers won't help him. Try as he might, Phil can't remember that night, and so, haunted by the need to know, he mind-reads his way through the lab techs at work, adoring fans at Toy Polloi, and anyone else who gets in his way, in an attempt to determine whether he's capable of such violence.

"Bioart is a new art form that has emerged from the cultural impact and increasing accessibilty of contemporary biotechnology. Signs of Life is the first book to focus exclusively on art that uses biotechnology as its medium, defining and discussing the theoretical and historical implications of bio art and offering examples of work by prominent artists. Bio art manipulates the processes of life; in its most radical form, it invents or transforms living organisms. It is not representational; bio art is in vivo. (A celebrated example is Eduardo Kac's own GFP Bunny, centered on Alba, the transgenic green rabbit.) The creations of bio art become a part of evolution and, provided they are capable of reproduction, can last as long as life exists on earth. Thus, bio art raises unprecedented questions about the future of life, evolution, society, and art. The contibutions to Signs of Life articulate the critical theory of bio art and documents its fundamental works. The writers - who include such prominent scholars as Barbara Maria Stafford, Eugene Thacker, and Dorothy Nelkin - consider the culture and aesthetics of biotechnology, the ethical and philosophical aspects of bio art, and biology in art history. The section devoted to artworks and artists including George Gessert's "Why I Breed Plants," Oron Catts and Ionat Zurr's "Semi-Living Art," Marc Quinn's "Genomic Portrait," and Heather Ackroyd and Dan Harvey's "Chlorophyll Apparitions.". --